Mobilization of peripheral blood progenitor cells for autografting: Chemotherapy and G-CSF or GM-CSF

S. Siena, M. Bregni, A. M. Gianni

Research output: Contribution to journalArticlepeer-review

Abstract

The mobilization of haematopoietic progenitor cells is a multifactorial process, still poorly understood at the molecular level. Mobilized haematopoietic progenitors, as defined by the expression of CD34 cell surface molecule, comprise heterogeneous subpopulations of cells committed to different haematopoietic lineages. Haematopoietic progenitors may be mobilized by chemotherapy alone, haematopoietic growth factors alone, or by chemotherapy plus haematopoietic growth factors. The choice of a mobilization regimen that allows an optimal yield of progenitors with a minimum number of leukaphereses should incorporate, in most patients, a disease-specific chemotherapeutic agent(s) plus a haematopoietic growth factor, to be continued until completion of harvest.

Original languageEnglish
Pages (from-to)27-39
Number of pages13
JournalBest Practice and Research: Clinical Haematology
Volume12
Issue number1-2
DOIs
Publication statusPublished - Mar 1999

Keywords

  • CD34 cells
  • Filgrastim
  • G-CSF
  • GM-CSF
  • Haematopoietic progenitor cells
  • Lenograstim
  • Mobilization
  • Molgramostim
  • Sargramostim

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Mobilization of peripheral blood progenitor cells for autografting: Chemotherapy and G-CSF or GM-CSF'. Together they form a unique fingerprint.

Cite this